Opendata, web and dolomites

Cardiacom IMPLANT

Intelligent human diagnostic and therapy platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Cardiacom IMPLANT project word cloud

Explore the words cloud of the Cardiacom IMPLANT project. It provides you a very rough idea of what is the project "Cardiacom IMPLANT" about.

disruptive    diagnostic    patients    parts    supporting    economic    treatment    operations    technological    pieces    physiological    packages    human    feasibility    evaluation    expanding    ict    drug    coverage    patient    regions    marketing    frequent    automated    service    markets    protocol    body    check    holistic    innovation    info    doctor    regional    drugs    organisational    profit    life    market    operated    holter    sale    entering    diseases    data    countries    turnover    financial    miniature    forecasting    subscription    ecomic    intelligent    treatments    communication    elaborated    oecd    disease    mortality    effectiveness    assessing    base    mobile    group    monitors    appointment    desired    appliances    business    achievements    fifth    lifelong    dealerships    distributor    outstanding    model    efficiency    safety    plan    crisis    geographical    return    people    improvement    cardiovascular    content    count    risk    launch    invasive    diffusion    optimized    algorithm    24    continous    implants    therapy    health    monitoring    initial    performing    benefits   

Project "Cardiacom IMPLANT" data sheet

The following table provides information about the project.

Coordinator
ATRACTOR KUTATASI, FEJLESZTESI ES SZOLGALTATO KFT 

Organization address
address: HERMINA UT. 57-59
city: BUDAPEST
postcode: 1146
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Hungary [HU]
 Project website http://www.atractorltd.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-12-01   to  2015-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ATRACTOR KUTATASI, FEJLESZTESI ES SZOLGALTATO KFT HU (BUDAPEST) coordinator 50˙000.00

Map

 Project objective

In OECD countries the most frequent cause of mortality is cardiovascular diseases. Addressing this problem needs a holistic approach, where ICT-based monitoring is in the focus.

The disruptive innovation programme sets the target of performing complex mobile invasive monitoring of cardiovascular and associated diseases, of forecasting the state of the patients, supporting the therapy treatments and assessing the effectiveness of drugs on mobile information-technology-base.

The devices are miniature holter monitors built into the human body, which with their diagnostic algorithm will regularly or continuously assess and check the physiological condition of the users.

Innovation content: 7/24 monitoring, continous data processing, intelligent automated evaluation systems, lifelong mobile crisis management, optimized drug taking protocol, implants with long life.

Main ecomic benefits: higher health and life safety, higher economic efficiency as a result of the improvement in people health condition, less patient-doctor appointment, reduced cost of cardiovascular treatment, reduced number of operations.

Main target group: patients who have been/will be operated on any cardiovascular disease and people who have high risk factor. The business model is built on the sale of appliances and on the sale of the related subscription-based info-communication service packages. According to the initial financial plan we count with a turnover of 100.000 pieces and an outstanding profit and return by the end of the fifth year after the market launch.

We plan the diffusion of the system in three steps with expanding geographical coverage. Before entering the markets we establish dealerships in the regions and develop a regional distributor and technical support system as well.

As desired achievements of the phase 1 five main parts of the Feasibility Study will be elaborated: Market Analysis Business Plan, Marketing Plan, Legal and Organisational Plan and Technological Plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACOM IMPLANT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACOM IMPLANT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

WIMUACT (2017)

TECHNOLOGY FOR THE IMPROVEMENT OF SPORTS PERFORMANCE IN NON-PROFESSIONAL CONTEXTS

Read More  

OE Scan (2018)

A next generation diagnostic device that effectively screens for breast cancer in all tissue types, without the use of ionising radiation

Read More  

GALERACLUSTER (2017)

Galera Cluster: World’s Most Advanced Technology to Protect Against Data Loss

Read More